Why MetLife, Inc. (MET) stock moved
MetLife, Inc. (MET) shares fell 1.1% to $92.99 as of July 21, 2026, a modest decline from the prior close of $94.00. BestStocks flagged the session as a major change for MET. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for MET, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
MET fell 1.1% to $92.99
MET fell 1.1% in its latest session, moving from $94.00 to $92.99.
What it means for MetLife, Inc. investors
For MetLife, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: MetLife, Inc. (MET) moved +0.32% from $93.70 to $94.00 on 2026-07-17; MetLife, Inc. (MET) moved +1.63% from $92.20 to $93.70 on 2026-07-16. Weighing against that: Negative session, down 1.1%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $98.22, implying +5.6% upside from $92.99. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
MET price reaction
MET last traded at $92.99, down $1.01 (-1.07%) from the previous close of $94.00. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $84.60 and $94.00, and it currently sits about 89% of the way up that band.
Bullish and bearish analyst opinions on MetLife, Inc. (MET)
The consensus analyst price target on MetLife, Inc. (MET) is $98.22, 5.6% above the recent $92.99. Over the past 90 days analysts logged 0 upgrades, 15 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MET line up.
The bullish case
- Wall Street's consensus price target of $98.22 implies +5.6% upside from $92.99.
- The Street's most bullish target is $105.00 (+12.9%).
- MetLife, Inc. (MET) moved +0.32% from $93.70 to $94.00 on 2026-07-17.
The bearish case
- The most bearish analyst target is $90.00 (-3.2%).
- Negative session, down 1.1%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MET
Frequently asked questions about MET
Why did MetLife, Inc. (MET) stock move?
MET fell 1.1% to $92.99. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did MET stock fall?
MET lost 1.07% ($1.01) versus the prior close of $94.00, last trading at $92.99 on 0.9× average volume.
When is MetLife, Inc.'s next earnings date?
MET's next earnings report is estimated for 2026-08-05 — about 15 days away.
What is the analyst price target for MET?
The consensus analyst price target for MET is $98.22, about 5.6% above the current $92.99. Over the past 90 days, analysts recorded 0 upgrades, 15 maintains, and 0 downgrades.
How BestStocks tracks MET
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MET-specific materiality thresholds, triggering an evidence check. It draws on 9 tracked change events for MET, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.